<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The authors have studied proliferation (growth fractions) in non-Hodgkin's <z:hpo ids='HP_0002665'>lymphomas</z:hpo> (NHL) using an immunohistochemical double staining technique with the monoclonal antibody (MoAb), Ki-67, in order to clarify the relationships between histologic type, proliferation and prognosis </plain></SENT>
<SENT sid="1" pm="."><plain>The percentages of Ki-67 positive (Ki-67+) cells in B cell <z:hpo ids='HP_0002665'>lymphomas</z:hpo> were higher for diffuse <z:hpo ids='HP_0002665'>lymphomas</z:hpo> than for follicular <z:hpo ids='HP_0002665'>lymphomas</z:hpo> and increased in order from small to large cell types </plain></SENT>
<SENT sid="2" pm="."><plain>In addition, the percentage of Ki-67+ cells in B cell <z:hpo ids='HP_0002665'>lymphomas</z:hpo> inversely correlated with survival in months (n = 33 r = -0.54 p &lt; 0.01) </plain></SENT>
<SENT sid="3" pm="."><plain>These results indicate that the percentage of Ki-67+ cells in B cell <z:hpo ids='HP_0002665'>lymphomas</z:hpo> correlates with histologic type and prognosis </plain></SENT>
<SENT sid="4" pm="."><plain>Although the prognosis of T cell <z:hpo ids='HP_0002665'>lymphomas</z:hpo> is considered worse than that of B cell <z:hpo ids='HP_0002665'>lymphomas</z:hpo>, the percentage of Ki-67+ cells was lower, in general, in T cell <z:hpo ids='HP_0002665'>lymphomas</z:hpo> than in B cell <z:hpo ids='HP_0002665'>lymphomas</z:hpo> </plain></SENT>
<SENT sid="5" pm="."><plain>These data indicate that proliferation in T cell <z:hpo ids='HP_0002665'>lymphomas</z:hpo> does not correlate with survival </plain></SENT>
</text></document>